Translational Neurodegeneration
BioMed Central Ltd · United Kingdom · Est. 1979
Aims & Scope✦ Inferred from recent articles
This journal focuses on neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), tauopathies, and Lewy body dementia (LBD). It covers research on disease mechanisms, biomarkers, and therapeutic strategies. Specific areas of interest include the role of protein aggregation (e.g., alpha-synuclein, tau), neuroinflammation, mitochondrial dysfunction, lysosomal pathways, and the gut-brain axis. The journal also explores novel therapeutic approaches such as stem cell therapies, ketogenic diets, drug repurposing, and interventions targeting cellular processes like autophagy and axonal transport.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref